Canadian Respiratory Journal

Canadian Respiratory Journal / 2019 / Article

Corrigendum | Open Access

Volume 2019 |Article ID 5906984 | https://doi.org/10.1155/2019/5906984

Nguyen Xuan Thanh, Philip Jacobs, Jason Suggett, Andrew McIvor, Alan Kaplan, "Corrigendum to “Cost-Effectiveness of the Aerobika® Oscillating Positive Expiratory Pressure Device in the Management of Chronic Obstructive Pulmonary Disease Exacerbations in Canada”", Canadian Respiratory Journal, vol. 2019, Article ID 5906984, 1 page, 2019. https://doi.org/10.1155/2019/5906984

Corrigendum to “Cost-Effectiveness of the Aerobika® Oscillating Positive Expiratory Pressure Device in the Management of Chronic Obstructive Pulmonary Disease Exacerbations in Canada”

Received17 Mar 2019
Accepted18 Mar 2019
Published19 May 2019

In the article titled, “Cost-Effectiveness of the Aerobika® Oscillating Positive Expiratory Pressure Device in the Management of Chronic Obstructive Pulmonary Disease Exacerbations in Canada” [1], the affiliation of the first author was incorrect. Also, the e-mail address of the first/corresponding author has been updated. The corrected authors’ list and affiliations are shown above.

References

  1. N. X. Thanh, P. Jacobs, J. Suggett, A. McIvor, and A. Kaplan, “Cost-effectiveness of the Aerobika® oscillating positive expiratory pressure device in the management of chronic obstructive pulmonary disease exacerbations in Canada,” Canadian Respiratory Journal, vol. 2019, Article ID 9176504, 7 pages, 2019. View at: Publisher Site | Google Scholar

Copyright © 2019 Nguyen Xuan Thanh et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder
Views513
Downloads233
Citations

Related articles

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.